Revenue: Not disclosed for QQ4 2024 (Revenue = null). YoY/QoQ not available.
Gross Profit: USD 32,162; YoY 390.69%; QoQ 409.79% (Note: Gross margin cannot be calculated without reported revenue in the period).
Operating Income: USD -906,000; YoY 60.44%; QoQ 50.55% (Negative due to high fixed/operating costs in a pre-revenue stage).
Net Income: USD -2,382,000; YoY 46.70%; QoQ 40.78% (Net loss persists despite some improvement in profitability metrics).
Earnings Per Share (EPS): -0.0005 USD; YoY 44.44%; QoQ 37.50% (Loss per share remains tiny on a massive share count base).
EBITDA: USD -2,372,000; reflects ongoing cash burn from core R&D and corporate costs.
Cash Flow: Operating cash flow -$72,095; Free cash flow -$98,371; Capital expenditures -$26,276. Net cash used in investing activities -$79,763; Net cash used in financing activities -$19,112. Net change in cash: -$170,970. Cash and cash equivalents: $39,044,795; Cash and short-term investments: $43,146,197; Net debt: -$38,998,966 (net cash position).
Balance Sheet Highlights: Total assets $43,367,816; Total liabilities $759,514; Total stockholders’ equity $41,723,202; Retained earnings negative at $(91,852,243).